FDA Approved: MILRINONE LACTATE IN DEXTROSE — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approved Baxter's supplemental application for milrinone lactate in dextrose under the ANDA pathway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure
• Heart Failure

Drugs mentioned

• MILRINONE LACTATE IN DEXTROSE (milrinone lactate in dextrose)

Snippet

SUPPL AP for MILRINONE LACTATE IN DEXTROSE (MILRINONE LACTATE)